Tests in

IDH1 and IDH2 Mutation Analysis

View Test

IGH/BCL2 t(14;18) FISH

  • Test Code:
    7360 • 7361 FFPE
  • Department:
    Cancer FISH
  • Test Synonyms:
    Follicular Lymphoma
View Test

IGH/CCND1 t(11;14) FISH

  • Test Code:
    7090 • 7091 FFPE
  • Department:
    Cancer FISH
  • Test Synonyms:
    Mantle Cell Lymphoma
View Test

Infantile Epilepsy Panel

  • Test Code:
  • Department:
    Molecular Genetics
  • Test Synonyms:
    West Syndrome • ADSL • ALDH5A1 • ALDH7A1 • AMT • ARX • BTD • CDKL5 • CLN3 • CLN5 • CLN6 • CLN8 • CNTNAP2 • CTSD • FOLR1 • FOXG1 • GABRG2 • GAMT • GCH1 • GLDC • GRIN2A • KCNJ10 • KCNQ2 • KCNQ3 • KCTD7 • LIAS • MAGI2 • MBD5 • MECP2 • MEF2C • MFSD8 • MMACHC • MTHFR • NRXN1 • PCBD1 • PHGDH • PNKP • PNPO • POLG • PPT1 • PRRT2 • PTS • QDPR • SCN1A • SCN1B • SCN2A • SCN8A • SLC25A22 • SLC2A1 • SLC6A8 • SLC9A6 • SPTAN1 • STXBP1 • TBC1D24 • TCF4 • TPP1 • TSC1 • TSC2 • UBE3A • WDR45 • ZEB2
View Test

Infantile Neuroaxonal Dystrophy, PLA2G6, Sequencing

  • Test Code:
    1682
  • Department:
    Molecular Genetics
  • Test Synonyms:
    INAD • PLA2G6-Related Infantile Neuroaxonal Dystrophy • Seitelberger Disease • NBIA • PLAN • Atypical NAD • Dystonia-parkinsonism
View Test

Inherited Breast Cancer Panel

  • Test Code:
    1691
  • Department:
    Inherited Cancer Syndromes • Molecular Genetics
  • Test Synonyms:
    ATM • BARD1 • BRCA1 • BRCA2 • BRIP1 • CDH1 • CHEK2 • NF1 • PALB2 • PTEN • RAD51C • RAD51D • STK11 • TP53
View Test

Inherited Breast/Gyn Cancer Panel

  • Test Code:
    1696
  • Department:
    Molecular Genetics
  • Test Synonyms:
    ATM • BRCA1 • BRCA2 • BRIP1 • CDH1 • CHEK2 • EPCAM • MLH1 • MSH2 • MSH6 • NBN • NF1 • PALB2 • PMS2 • PTEN • RAD51C • RAD51D • STK11 • TP53
View Test

Inherited Cancer Panel

  • Test Code:
    1690
  • Department:
    Molecular Genetics
  • Test Synonyms:
    Familial Cancer • Hereditary Cancer • Breast Cancer • Ovarian Cancer • Endometrial Cancer • Colon Cancer • Colorectal cancer • Lynch Syndrome • Renal Cancer • Pancreatic Cancer • Multiple Endocrine Neoplasia • Melanoma • Birt-Hogg-Dube • Carney Complex • Gorlin Syndrome • APC • ATM • AXIN2 • BAP1 • BARD1 • BMPR1A • BRCA1 • BRCA2 • BRIP1 • CDH1 • CDK4 • CDKN1B • CDKN2A • CHEK2 • CTNNA1 • DICER1 • EPCAM • FH • FLCN • GREM1 • HOXB13 • KIT • MAX • MBD4 • MEN1 • MET • MLH1 • MLH3 • MRE11A • MSH2 • MSH3 • MSH6 • MUTYH • NF1 • NTHL1 • PALB2 • PMS2 • POLD1 • POLE • PRKAR1A • PTCH1 • PTEN • RAD51C • RAD51D • RET • SDHA • SDHAF2 • SDHB • SDHC • SDHD • SMAD4 • SMARCA4 • STK11 • TMEM127 • TP53 • TSC1 • TSC2 • VHL
View Test

Inherited Colon Cancer Panel

View Test

Inherited Ovarian Cancer Panel

View Test
Innovations in Testing
View All Tests

The Knight Cancer Institute at Oregon Health & Science University is a pioneer in the field of precision cancer medicine. The institute's director, Brian Druker, M.D., helped prove it was possible to shut down just the cells that enable cancer to grow. This breakthrough has made once-fatal forms of the disease manageable and transformed how cancer is treated. The OHSU Knight Cancer Institute is the only National Cancer Institute-designated Cancer Center between Sacramento and Seattle – an honor earned only by the nation's top cancer centers. It is headquarters for one of the National Cancer Institute's largest research collaboratives, SWOG, in addition to offering the latest treatments and technologies as well as hundreds of research studies and clinical trials.

Learn More